Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

There are less than 72 hours left in this Mid-Year Campaign and our independent journalism needs your help today.
If you value our work, please support Common Dreams. This is our hour of need.

Join the small group of generous readers who donate, keeping Common Dreams free for millions of people each year. Without your help, we won’t survive.

Demonstrators protest outside Pfizer's headquarters in Manhattan.

People gather for a protest at Pfizer's Manhattan headquarters demanding equal distribution of coronavirus vaccines on July 14, 2021. (Photo: Michael M. Santiago/Getty Images)

After Year of Vaccine Profiteering, Pfizer Hikes Prices on 125 Drugs

"Drug corporations can do this because we let them—unlike other nations that use their purchasing power to get a better deal," said David Mitchell of Patients for Affordable Drugs.

Jake Johnson

After raking in enormous profits from its coronavirus vaccine in 2021, the U.S.-based pharmaceutical giant Pfizer has kicked off the new year by hiking the prices of more than 120 of its drugs, resulting in significantly higher costs for patients amid a deadly pandemic.

That's according to a new report released Thursday by Patients for Affordable Drugs (P4AD), which found that pharmaceutical companies have raised the prices of 554 medicines this month alone. Pfizer led the way with 125 price hikes to start 2022, leading P4AD to label the company the industry's "poster child for greed."

"The drug pricing legislation agreed to in the Build Back Better Act would curb rising drug prices for millions."

"Due to sales of its Covid-19 vaccine, which is set to be the best-selling drug of all time, Pfizer shattered profit records in 2021. Projected sales for 2022 are $54.5 billion—more than double the previous record for one-year sales for a prescription drug," the report notes. "To put this into perspective, AbbVie's Humira previously held the spot with $19.8 billion in sales, and Pfizer’s best-selling product just prior to the pandemic achieved worldwide revenues of $5.8 billion."

"Despite this record revenue in 2021," the report continues, "Pfizer began 2022 with price hikes on seven of its 10 best-selling drugs," including its pneumonia vaccine (up 6.9%), a breast cancer medication (up 6.9%), and a treatment for people with cardiovascular disease (up 6%).

"These hikes of 5% or 6% can translate into thousands of dollars in higher costs for patients," P4AD notes.

Ashley Suder, a West Virginia resident who takes Pfizer's Eliquis to manage her autoimmune disease, told P4AD that she has had to spend her "entire paycheck" on medication and will likely be taking Eliquis for the rest of her life.

"With the price increasing again," said Suder, "I worry about how I'll make ends meet while still affording my drugs."

Pfizer chart

While the worst offenders, Pfizer and its subsidiaries were hardly alone in raising drug costs for patients during the first month of 2022, according to P4AD, which also spotlighted price hikes by Gilead, Eli Lilly, and other prominent pharmaceutical companies.

"So far in 2022," the group noted in a press release, "drug companies have increased prices on 554 drugs, 183 drugs were hiked by $100 or more, and 118 drugs with increases carry a price over $5,000. The average price hike was 6.3%, and one in four price hikes exceeded the most recently available inflation rate at the time of analysis."

David Mitchell, P4AD's founder and a blood cancer patient whose medications have a list price of more than $900,000 annually, said in a statement Thursday that "even as we enter the third year of a pandemic, Big Pharma continues its practice of targeting American patients and consumers with price increases, completely undeterred by the financial and health challenges facing American families."

"Drug corporations can do this because we let them—unlike other nations that use their purchasing power to get a better deal," Mitchell added.

The Build Back Better Act, Democrats' $1.75 trillion reconciliation package, includes provisions that would let Medicare negotiate the prices of a limited subset of prescription drugs directly with pharmaceutical corporations, something it is currently barred from doing by law—a prohibition that has contributed to sky-high medicine costs in the U.S.

Democrats' legislation would also penalize drug companies that hike prices faster than the rate of inflation, which is currently at a 40-year high.

But the House-passed bill remains stuck in the Senate as Sen. Joe Manchin (D-W.Va.) demands the removal of key Democratic priorities, including the expanded child tax credit and investments in affordable housing. Democrats are expected to continue working to advance the legislation in the coming days.

"The drug pricing legislation agreed to in the Build Back Better Act would curb rising drug prices for millions of patients and halt abusive annual price hikes by limiting increases to the rate of inflation, which is projected to return to 2.3% in 2023," Mitchell said Thursday. "The Senate must pass this legislation immediately."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

Just a few days left in our crucial Mid-Year Campaign and we might not make it without your help.
Who funds our independent journalism? Readers like you who believe in our mission: To inform. To inspire. To ignite change for the common good. No corporate advertisers. No billionaire founder. Our non-partisan, nonprofit media model has only one source of revenue: The people who read and value this work and our mission. That's it.
And the model is simple: If everyone just gives whatever amount they can afford and think is reasonable—$3, $9, $29, or more—we can continue. If not enough do, we go dark.

All the small gifts add up to something otherwise impossible. Please join us today. Donate to Common Dreams. This is crunch time. We need you now.

Markey, Bowman Join Climate Coalition in Urging SCOTUS Expansion

"We cannot sit idly by," said Markey, "as extremists on the Supreme Court eviscerate the authorities that the government has had for decades to combat climate change and reduce pollution."

Brett Wilkins ·


Ocasio-Cortez Says US 'Witnessing a Judicial Coup in Process'

"It is our duty to check the Court's gross overreach of power in violating people's inalienable rights and seizing for itself the powers of Congress and the president."

Brett Wilkins ·


Critics Say Biden Drilling Bonanza 'Won't Lower Gas Prices' But 'Will Worsen Climate Crisis'

"President Biden's massive public lands giveaway in the face of utter climate catastrophe is just the latest sign that his climate commitments are mere rhetoric," said one campaigner.

Kenny Stancil ·


Grave Warnings as Supreme Court Agrees to Hear Case That Threatens 'Future of Voting Rights'

"Buckle up," implores one prominent legal scholar. "An extreme decision here could fundamentally alter the balance of power in setting election rules in the states and provide a path for great threats to elections."

Brett Wilkins ·


Biden Urged to Take Emergency Action After 'Disastrous' Climate Ruling by Supreme Court

"The catastrophic impact of this decision cannot be understated," said Rep. Pramila Jayapal, but "we cannot accept defeat."

Kenny Stancil ·

Common Dreams Logo